<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38229583</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2265</ISSN><JournalIssue CitedMedium="Internet"><Volume>100</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Clinical endocrinology</Title><ISOAbbreviation>Clin Endocrinol (Oxf)</ISOAbbreviation></Journal><ArticleTitle>Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19.</ArticleTitle><Pagination><StartPage>317</StartPage><EndPage>327</EndPage><MedlinePgn>317-327</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cen.15012</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Endocrine systems are disrupted in acute illness, and symptoms reported following coronavirus disease 2019 (COVID-19) are similar to those found with clinical hormone deficiencies. We hypothesised that people with severe acute COVID-19 and with post-COVID symptoms have glucocorticoid and sex hormone deficiencies.</AbstractText><AbstractText Label="DESIGN/PATIENTS">Samples were obtained for analysis from two UK multicentre cohorts during hospitalisation with COVID-19 (International Severe Acute Respiratory Infection Consortium/World Health Organisation [WHO] Clinical Characterization Protocol for Severe Emerging Infections in the UK study), and at follow-up 5 months after hospitalisation (Post-hospitalisation COVID-19 study).</AbstractText><AbstractText Label="MEASUREMENTS">Plasma steroids were quantified by liquid chromatography-mass spectrometry. Steroid concentrations were compared against disease severity (WHO ordinal scale) and validated symptom scores. Data are presented as geometric mean (SD).</AbstractText><AbstractText Label="RESULTS">In the acute cohort (n&#x2009;=&#x2009;239, 66.5% male), plasma cortisol concentration increased with disease severity (cortisol 753.3 [1.6] vs. 429.2 [1.7]&#x2009;nmol/L in fatal vs. least severe, p&#x2009;&lt;&#x2009;.001). In males, testosterone concentrations decreased with severity (testosterone 1.2 [2.2] vs. 6.9 [1.9]&#x2009;nmol/L in fatal vs. least severe, p&#x2009;&lt;&#x2009;.001). In the follow-up cohort (n&#x2009;=&#x2009;198, 62.1% male, 68.9% ongoing symptoms, 165 [121-192] days postdischarge), plasma cortisol concentrations (275.6 [1.5]&#x2009;nmol/L) did not differ with in-hospital severity, perception of recovery, or patient-reported symptoms. Male testosterone concentrations (12.6 [1.5]&#x2009;nmol/L) were not related to in-hospital severity, perception of recovery or symptom scores.</AbstractText><AbstractText Label="CONCLUSIONS">Circulating glucocorticoids in patients hospitalised with COVID-19 reflect acute illness, with a marked rise in cortisol and fall in male testosterone. These findings are not observed 5 months from discharge. The lack of association between hormone concentrations and common post-COVID symptoms suggests steroid insufficiency does not play a causal role in this condition.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. Clinical Endocrinology published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Devine</LastName><ForeName>Kerri</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>BHF/University Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh Bioquarter, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Clark D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco</LastName><ForeName>Giovanny R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Edinburgh Cancer Research UK Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Brian R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>BHF/University Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh Bioquarter, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Homer</LastName><ForeName>Natalie Z M</ForeName><Initials>NZM</Initials><AffiliationInfo><Affiliation>BHF/University Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh Bioquarter, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mass Spectrometry Core, Edinburgh Clinical Research Facility, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denham</LastName><ForeName>Scott G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Mass Spectrometry Core, Edinburgh Clinical Research Facility, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Joanna P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Mass Spectrometry Core, Edinburgh Clinical Research Facility, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leavy</LastName><ForeName>Olivia C</ForeName><Initials>OC</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elneima</LastName><ForeName>Omer</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAuley</LastName><ForeName>Hamish J C</ForeName><Initials>HJC</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shikotra</LastName><ForeName>Aarti</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singapuri</LastName><ForeName>Amisha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sereno</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saunders</LastName><ForeName>Ruth M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Victoria C</ForeName><Initials>VC</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houchen-Wolloff</LastName><ForeName>Linzy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greening</LastName><ForeName>Neil J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lone</LastName><ForeName>Nazir I</ForeName><Initials>NI</Initials><AffiliationInfo><Affiliation>Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thorpe</LastName><ForeName>Mathew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Medical Informatics, The Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenhalf</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalmers</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Ling-Pei</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>MRC Human Immunology Unit, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horsley</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marks</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital for Tropical Diseases, University College London Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infection and Immunity, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raman</LastName><ForeName>Betty</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Radcliffe Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Shona C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunning</LastName><ForeName>Jake</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pandemic Sciences Institute, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semple</LastName><ForeName>Malcolm G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrew</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>BHF/University Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh Bioquarter, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mass Spectrometry Core, Edinburgh Clinical Research Facility, Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wain</LastName><ForeName>Louise V</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Rachael A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brightling</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenneth Baillie</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Genetics and Genomics, Roslin Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Rebecca M</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0001-6226-8270</Identifier><AffiliationInfo><Affiliation>BHF/University Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh Bioquarter, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ISARIC4C Investigators and PHOSP-COVID Study Collaborative Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Endocrinol (Oxf)</MedlineTA><NlmUniqueID>0346653</NlmUniqueID><ISSNLinking>0300-0664</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013256">Steroids</NameOfSubstance></Chemical><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance UI="D013739">Testosterone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000359" MajorTopicYN="N">Aftercare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013256" MajorTopicYN="N">Steroids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID 19</Keyword><Keyword MajorTopicYN="N">adrenal</Keyword><Keyword MajorTopicYN="N">cortisol</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">testosterone</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>17</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38229583</ArticleId><ArticleId IdType="doi">10.1111/cen.15012</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an International Task Force by the American College of Critical Care Medicine. Crit Care Med. 2008;36(6):1937-1949.</Citation></Reference><Reference><Citation>Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693-704.</Citation></Reference><Reference><Citation>Spratt DI, Bigos ST, Beitins I, Cox P, Longcope C, Orav J. Both hyper- and hypogonadotropic hypogonadism occur transiently in acute illness: bio- and immunoactive gonadotropins. J Clin Endocrinol Metab. 1992;75(6):1562-1570.</Citation></Reference><Reference><Citation>Tan T, Khoo B, Mills EG, et al. Association between high serum total cortisol concentrations and mortality from Covid-19. Lancet Diabetes Endocrinol. 2020;8(8):659-660.</Citation></Reference><Reference><Citation>Alzahrani AS, Mukhtar N, Aljomaiah A, et al. The impact of Covid-19 viral infection on the hypothalamic-pituitary-adrenal axis. Endocr Pract. 2021;27(2):83-89.</Citation></Reference><Reference><Citation>Das L, Dutta P, Walia R, et al. Spectrum of endocrine dysfunction and association with disease severity in patients with Covid-19: insights from a cross-sectional, observational study. Front Endocrinol. 2021;12:645787.</Citation></Reference><Reference><Citation>Mao Y, Xu B, Guan W, et al. The adrenal cortex, an underestimated site of SARS-CoV-2 infection. Front Endocrinol. 2021;11(1060):593179.</Citation></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et al. Physical, cognitive, and mental health impacts of Covid-19 after hospitalisation (Phosp-Covid): a uk multicentre, prospective cohort study. Lancet Respir Med. 2021;9(11):1275-1287.</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-Covid-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102-e107.</Citation></Reference><Reference><Citation>Papadopoulos AS, Cleare AJ. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat Rev Endocrinol. 2011;8(1):22-32.</Citation></Reference><Reference><Citation>Clarke SA, Phylactou M, Patel B, et al. Normal adrenal and thyroid function in patients who survive Covid-19 infection. J Clin Endocrinol Metab. 2021;106(8):2208-2220.</Citation></Reference><Reference><Citation>Marshall JC, Murthy S, Diaz J, et al. A minimal common outcome measure set for Covid-19 clinical research. Lancet Infect Dis. 2020;20(8):e192-e197.</Citation></Reference><Reference><Citation>Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with Covid-19 using the isaric who clinical characterisation protocol: development and validation of the 4c mortality score. BMJ. 2020;370:m3339.</Citation></Reference><Reference><Citation>Laboratory Corporation of America&#xae; Holdings. Endocrinology Expected Values and S.I. Unit Conversion Tables. 2021. Accessed June 20, 2023. https://specialtytesting.labcorp.com/sites/default/files/2021-07/L5167-0421-18%20Endocrine%20Expected%20Values_0.pdf</Citation></Reference><Reference><Citation>Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.</Citation></Reference><Reference><Citation>Remmelts HHF, Meijvis SCA, Kovaleva A, Biesma DH, Rijkers GT, Heijligenberg R. Changes in serum cortisol levels during community-acquired pneumonia: the influence of dexamethasone. Respir Med. 2012;106(6):905-908.</Citation></Reference><Reference><Citation>Sam S, Corbridge TC, Mokhlesi B, Comellas AP, Molitch ME. Cortisol levels and mortality in severe sepsis. Clin Endocrinol. 2004;60(1):29-35.</Citation></Reference><Reference><Citation>Chapman KE, Coutinho AE, Zhang Z, Kipari T, Savill JS, Seckl JR. Changing glucocorticoid action: 11&#x3b2;-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation. J Steroid Biochem Mol Biol. 2013;137(100):82-92.</Citation></Reference><Reference><Citation>Cohen J, Smith ML, Deans RV, et al. Serial changes in plasma total cortisol, plasma free cortisol, and tissue cortisol activity in patients with septic shock: an observational study. Shock. 2012;37(1):28-33.</Citation></Reference><Reference><Citation>Walker BR, Campbell JC, Fraser R, Stewart PM, Edwards CRW. Mineralocorticoid excess and inhibition of 11 &#x3b2;-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol. 1992;37(6):483-492.</Citation></Reference><Reference><Citation>Annane D, Pastores SM, Rochwerg B, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (Circi) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017;43(12):1751-1763.</Citation></Reference><Reference><Citation>Dorward DA, Russell CD, Um IH, et al. Tissue-specific immunopathology in fatal Covid-19. Am J Respir Crit Care Med. 2021;203(2):192-201.</Citation></Reference><Reference><Citation>Leow MK-S, Kwek DS-K, Ng AW-K, Ong K-C, Kaw GJ-L, Lee LS-U. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol. 2005;63(2):197-202.</Citation></Reference><Reference><Citation>Sunada N, Honda H, Nakano Y, et al. Hormonal trends in patients suffering from long Covid symptoms. Endocr J. 2022;69:1173-1181.</Citation></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute Covid-19 sequelae. Cell. 2022;185(5):881-895.</Citation></Reference><Reference><Citation>Dhindsa S, Zhang N, McPhaul MJ, et al. Association of circulating sex hormones with inflammation and disease severity in patients with Covid-19. JAMA Netw Open. 2021;4(5):e2111398.</Citation></Reference><Reference><Citation>Fourrier F, Jallot A, Leclerc L, et al. Sex steroid hormones in circulatory shock, sepsis syndrome, and septic shock. Circ Shock. 1994;43(4):171-178.</Citation></Reference><Reference><Citation>Liu X, Chen Y, Tang W, et al. Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene Ace2 expression in normal and non-obstructive azoospermia (NOA) human male testes. Science China Life Sciences. 2020;63(7):1006-1015.</Citation></Reference><Reference><Citation>Pan F, Xiao X, Guo J, et al. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Fertil Steril. 2020;113(6):1135-1139.</Citation></Reference><Reference><Citation>Chu KY, Nackeeran S, Horodyski L, Masterson TA, Ramasamy R. Covid-19 infection is associated with new onset erectile dysfunction: insights from a National Registry. Sex Med. 2022;10(1):100478-1.</Citation></Reference><Reference><Citation>Moreno-Perez O, Merino E, Alfayate R, et al. Male pituitary-gonadal axis dysfunction in post-acute Covid-19 syndrome-prevalence and associated factors: a Mediterranean case series. Clin Endocrinol. 2022;96(3):353-362.</Citation></Reference><Reference><Citation>Salonia A, Pontillo M, Capogrosso P, et al. Testosterone in males with Covid-19: a 12-month cohort study. Andrology. 2023;11(1):17-23.</Citation></Reference><Reference><Citation>Wu FCW, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123-135.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>